Wedemark, Germany

Rainer Walenta


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1989-1991

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rainer Walenta: Innovator in Pharmaceutical Chemistry

Introduction

Rainer Walenta is a notable inventor based in Wedemark, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that exhibit inflammation-inhibiting pharmacological activity. With a total of two patents to his name, Walenta's work is recognized for its potential impact on medical treatments.

Latest Patents

Walenta's latest patents include innovative compounds known as 3-flavone carboxylic acid compounds. These compounds correspond to a specific formula where various groups represent hydrogen, lower alkyl, halogen, hydroxy, or etherified or esterified hydroxy. Additionally, the compounds are designed to exhibit inflammation-inhibiting pharmacological activity. Another patent focuses on flavone-3-carboxylic acid compounds, which also correspond to a similar formula and share the same pharmacological benefits.

Career Highlights

Rainer Walenta is currently associated with Kali-Chemie Pharma GmbH, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation in pharmaceutical applications, particularly in the area of anti-inflammatory compounds.

Collaborations

Walenta collaborates with esteemed colleagues such as Reiner Muller-Peddinghaus and Ivan Ban. These partnerships enhance the research and development process, fostering an environment of shared knowledge and expertise.

Conclusion

Rainer Walenta's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments aimed at reducing inflammation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…